Azienda Ospedaliero Universitaria di Sassari
15
3
3
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 15 trials
100.0%
+13.5% vs industry average
27%
4 trials in Phase 3/4
25%
1 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (15)
Tele-rehabilitation Versus Center-based Rehabilitation in Heart Failure Patients
Role: lead
Effect of Prehabilitation on Head and Neck Cancer Patients
Role: collaborator
Chest CT Biomarkers as Prognostic Predictors in SSc-ILD
Role: collaborator
GenLab: Unveiling the Genetic Landscape of Brugada Syndrome: Novel Biomarker Discovery for Precise Diagnosis
Role: collaborator
Prevention of Post mEniscectomy Osteoarthritis: From New Animal Model to Patient pRofiLing
Role: collaborator
Proof of Concept of Remote Management of Chronic Inflammatory Airway Diseases for Patient Empowerment
Role: lead
Validation Study of a Serum-miRNA Signature in Glioma Patients.
Role: collaborator
Olfactory Disfunction and Co-ultraPEALut
Role: collaborator
Different Ribavirin Dosages and Different Duration of Treatment in Combination With PegInterferon in Patients With Genotype 2 and 3 (WRITE)
Role: collaborator
Clinical Observational Registry of Patients With Left Bundle Branch Block
Role: lead
Ticagrelor Administered as Standard Tablet or Orodispersible Formulation
Role: lead
Respiratory Function in Patients With Post-tuberculosis Lung Impairment
Role: collaborator
The Italian REgistry of Pulmonary Non-tuberculous mycobactEria
Role: collaborator
Endothelial Dysfunction Evaluation for Coronary Heart Disease Risk Estimation in Rheumatoid Arthritis (EDRA Study)
Role: lead
Ezetimibe/Simvastatin Combination in Proteinuric Nephropathy
Role: lead
All 15 trials loaded